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Moyamoya disease is an uncommon cerebrovascular condition characterized by 
progressive occlusion of bilateral internal carotid arteries, and is known to cause strokes 
in relatively younger people.[1, 2] Several efforts to identify its pathogenesis have 
recently detected gene mutations and deletions that make people susceptible to the 
familial form of the disease, and further investigation might clarify the direct 
mechanisms underlying the disease.[3-6] Extracranial-intracranial bypass surgery has 
been established as an effective neurosurgical intervention that increases cerebral blood 
flow (CBF) and guards against ischemic attacks. However, difficulty with social 
independence accompanied by cognitive impairment has recently been recognized as an 
important unsolved social issue faced by patients with adult moyamoya disease.[7] 
These patients are physically independent in daily life, but economically dependent 
because cognitive impairment leads to difficulty obtaining vocational skills. Here, we 
define the status of these patients as “difficulty with social independence.” Generally, 
cognitive impairment has been described as a neuropsychological sequela occurring 
after strokes that manifests as disturbances in memory, attention, performance, and 
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social behavioral in pediatric cases.[8, 9] However, recent reports have focused on adult 
cases with neurocognitive impairment even without radiological evidence of major 
stroke.[7, 10] Nakagawara et al. indicated that even if infarction has not yet occurred, 
brain dysfunction was associated with persistent hemodynamic compromise in the 
medial frontal lobes that can be visualized using [123I]iomazenil (IMZ)-single photon 
emission CT (SPECT). This technique has the potential to become a tool for diagnosing 
cognitive impairment in adult moyamoya patients who do not show major abnormalities 
on CT scans or magnetic resonance imaging (MRI). In contrast, a common 
methodology for neuropsychological evaluation of these patients is yet to be determined, 
even to the extent that which questions to include remains undecided. Because previous 
studies have selected considerably different tasks for this evaluation, results have been 
unsurprisingly in consistent.[10-12] Therefore, we address this concern by 
administering structured tests to two groups of adult moyamoya patients, one with 
difficulty in social independence, and the other without.  
 
Materials and Methods  
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Participants  
Ten patients with neuroradiologically confirmed adult moyamoya disease (3 men and 7 
women; mean age: 34.2 years; range, 19–51 years) participated in this study. Since this 
survey was formed by completely anonymous retrospective information, this study did 
not have the ethics committee approval. All subjects were proficient in Japanese. To 
identify specifics regarding neuropsychological assessment in moyamoya patients who 
have difficulty with social independence, the 10 patients were divided into two groups. 
Group 1 comprised five patients without difficulty in social independence. The subjects 
in this group had a higher educational background without need for special education 
programs, better socioeconomic status, and did not need public support. Group 2 
comprised five patients who had difficulty with social independence. Two of the five 
patients required a special education program, and all were socioeconomically 
disadvantaged and needed public support. The mean duration of the disease was 9.1 
years. Only one patient had a history of small intracerebral hemorrhage (periventricular 
region) at onset. Other patients had histories of transient ischemic attacks or minor 
ischemic strokes. MRI revealed these minor strokes in four patients, while the 
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remaining subjects showed no abnormalities in the radiological assessment. No 
subjects showed radiological abnormality evidenced by an ischemic lesion affected by 
more than two cortical arteries. [123I]iodoamphetamine (IMP)-SPECT showed one case 
of resting-state CBF impairment in Group 1 and three cases in Group 2. 
Cerebrovascular reserve (CVR) impairment was found in nine of the ten cases. 
Revascularization surgery comprising superficial temporal artery-middle cerebral artery 
bypass was performed in nine of the ten patients and their preoperative symptoms were 
relieved. All patients were physically independent, with modified Rankin Scale scores 
no greater than 2 at the time of study inclusion. Table 1 and Table 2 summarize the 
clinical characteristics and radiological features of each patient group.  
 
Neuropsychological Assessment  
Basic cognitive ability was evaluated using the Wechsler Adult Intelligence Scale-Third 
Edition (WAIS-III) to assess intelligence, the Wechsler Memory Scale-Revised 
(WMS-R) to assess memory[13, 14], and supplemental subtests for each task. Several 
frontal-functioning tests were also administered to detect specific neuropsychological 
 7 
deficits associated with adult moyamoya disease that co-occurs with difficulty in social 
independence. The Frontal Assessment Battery (FAB) tested general frontal cognitive 
ability. The Trail Making Test Part A (TMT-A) assessed speed of information 
processing[15, 16] and the Trail Making Test Part B (TMT-B) and the Wisconsin Card 
Sorting Test assessed executive ability.[16, 17] The Go/No-Go and No-Go/Go tasks 
were used to measure response inhibition[18] and the Apathy Scale measured the extent 
of apathy. The Reading the Mind in the Eyes (Eyes) task is a theory-of-mind task that 
was given to examine the ability to infer the mental status of others.[19]   
 
Data Analysis  
To identify group differences regarding clinical profiles and neuropsychological tasks, a 
univariate analysis was performed. P-values were calculated based on the two-tailed 
t-test for parametric data and the Mann-Whitney U test for non-parametric data. Next, to 
determine which factors contributed to the differentiation between groups, a 
discriminate analysis was applied to the data set. A predictive model was then 
constructed following a stepwise variable selection procedure. Finally, the contribution 
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rate that discriminated between the groups and the expected classification rate were 
calculated along with their F- and P-values. These statistical data were generated using 
JMP software, Version 10.0.2 (SAS Institute Inc., Cary, NC, USA). A p-value less than 
0.05 was considered statistically significant. 
 
Results  
The mean scores for clinical variables and neuropsychological assessments of each 
patient group are given in Table 3. The mean age of Group 1 was substantially higher 
than that of Group 2, but the disease duration for each group was not significantly 
different. Group 1 also had significantly higher mean scores than Group 2 for 
intelligence functions including subtests for basic cognitive abilities. In contrast, scores 
for memory functions showed significant differences in three subtests (General Index, 
Attention/Concentration Index, and Delayed Index) between groups. Although scores 
were equivalent between groups on a number of tasks that assessed frontal lobe 
functions, those obtained from the TMT-B test were significantly higher in Group 2, 
while those from the Eyes test were significantly higher in Group 1. After loading all 
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data from neuropsychological tasks into statistical software, a discriminate analysis was 
performed. The result indicated that the Working Memory (a WAIS-III subtest) and 
Eyes tasks contributed significantly to the discrimination of the groups (Table 4).  
 
Discussion 
The present study demonstrated that impairments were mainly in intelligence and 
memory function. Additionally, some frontal lobe function was particularly affected in 
adult moyamoya patients with difficulty in social independence. 
 
Evaluation of the results in this study  
Neuropsychological examination  
Recent work using IMZ-SPECT has demonstrated the association between cortical 
neuron loss in bilateral frontal medial cortices and cognitive dysfunction. Considering 
that evidence, we have adopted several tasks to examine frontal lobe functions. To date, 
this is the first adoption of this comparative method regarding cognitive function of 
moyamoya disease.[7, 9-12, 20-22] Therefore, the data presented here are novel and not 
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comparable with prior studies. A definition of “neurocognitive dysfunction” using the 
evaluations from all the proposed tasks was not presumed in considering the objective 
of this study.  
 
Intelligence and Memory function 
On measures of intelligence abilities using WAIS-III and its subtests, mean scores from 
all patients in Group 2 were found to be lower than that of Group 1. Previous research 
has demonstrated loss of intellectual functions in pediatric-onset cases.[8, 9, 20, 23, 24] 
Our results from Group 2 were consistent with those based on the age of onset. In 
contrast, the mean level of intelligence ability in Group 1 was preserved. These data are 
consistent with a report suggesting cognition in adult moyamoya cases is relatively 
spared.[22] The proportion of gainfully employed subjects in that report (84%) is 
comparable that in this one (80%). Interestingly, within Group 1, Working Memory 
scores were lower compared to scores from other WAIS-III subtests. This may be 
specifically related to adult moyamoya cases that do not include difficulty with social 
independence. The underlying CBF impairment or neuronal loss induced by prolonged 
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hemodynamic compromise could lead to a mild disorder in intellectual functioning that 
manifests in working-memory deficits. However, memory ability assessed by the 
WMS-R was not different from other abilities, including those assessed by all WMS-R 
subtests. This highlights the difficulty assessing memory status in the adult moyamoya 
population, which is still controversial. While Festa et al. have reported an overall 
memory score 1.1 SDs below the mean of healthy individuals,[12] other reports have 
shown memory to be unaffected in adult moyamoya subjects.[11, 22] Usually, a lack of 
memory impairment associated with spared hypoperfusion in the medial temporal lobe 
is characteristic of moyamoya disease. However, our results showing impairment within 
Group 2 on three subtests of the WMS-R could not be explained from the SPECT data, 
indicating specific hypoperfusion in the rest state and impaired CVR in the medial 
temporal lobe. This point remains unresolved, whereas memory function may be 
associated not only with the medial temporal lobe but also with wide-spread subcortical 
neuronal connections. 
 
Frontal lobe functions  
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An extensive focus on frontal lobe function has not yet been taken by previous research 
regarding moyamoya disease. CBF and IMZ studies have shown that antero-medial 
frontal cortices fed by anterior circulation develop blood insufficiencies.[7, 25] For this 
reason, several neuropsychological test batteries to evaluate frontal lobe functioning in 
relation with hemodynamic compromise were employed for this preliminary study. 
Among these batteries, only scores from the TMT-B and Eyes tasks were shown to be 
statistically lower in Group 1 compared with Group 2. The TMT-B can estimate frontal 
lobe function in terms of problem solving and motor planning.[26] Performance on this 
test is known to be poor in adult patients with moyamoya disease,[12, 22] and results 
from Group 2, required time to complete the task was longer than Group 1, were 
compatible with these other studies. Theory-of-mind tasks examine one’s ability to infer 
the mental status of others. Here we employed the revised version of the Reading the 
Mind in the Eyes test.[19, 27] This test had been given to patients with other kinds of 
psychiatric disorders, and recent neuroimaging studies of normal subjects indicate that 
performing the Eyes task activates linked brain regions including the medial prefrontal 
cortex, the orbitofrontal cortex, the amygdala, the temporal poles and the superior 
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temporal sulcus.[28] Hirao et al. has demonstrated that the mean accuracy in the Eyes 
task generated by schizophrenic patients was significantly lower than that of normal 
subjects.[27] Furthermore, they provided a correlation analysis between Eyes-task 
impairment and structural alterations using Voxel-based morphometry, which indicated 
specific regional abnormalities in the left ventrolateral prefrontal cortex of 
schizophrenia patients. To our knowledge, this is the first report to show deficiency in 
theory-of-mind ability in patients with moyamoya disease. Though we did not include a 
structural study, long-term chronic hypoperfusion in the anterior circulation could 
produce a dysfunction in medial and lateral regions of the anterior frontal lobe, which 
might induce the theory-of-mind impairment observed in Group 2.  
 
Discriminate analysis 
To determine which neuropsychological tasks can best detect neurocognitive 
dysfunction in adult patients with moyamoya disease in a clinical setting, we conducted 
a discriminate analysis using crude data from all neuropsychological tasks. Results 
showed that the Working Memory and Eyes tasks were the best predictors, and a model 
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limited to those tasks successfully classified the patients into two groups. This indicates 
that these two tasks have the statistical power to diagnose neurocognitive dysfunction in 
adult patients with moyamoya disease. Impairment of these tasks could be the specific 
neurocognitive deficits that inflict adult moyamoya patients. 
 
Limitations  
There are several limitations to this preliminary study. First, the definition of “difficulty 
with social independence” is still unclear, and selecting these patients was not objective, 
so it may be biased. A structured evaluation system determined through a multi-center 
study is required. Second, in considering the effect of CBF on neurocognitive function, 
a history of revascularization surgery should be matched. However, the aim of this study 
is not to compare neurocognitive function before and after the revascularization surgery, 
but to collect long-term consequence of neurocognitive function in adult patients with 
moyamoya disease. Third, the number of patients enrolled in this study was too small. 
Characteristics such as age, type of onset, radiological abnormality were not matched 
between groups. However, it is particularly worth nothing that the several group 
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differences were revealed even in small set of patients and detailed neuropsychological 
tasks. This preliminary study would be fundamental data for a large-scale research and 
contribute to understand the characteristics of cognitive dysfunction in adult patients 
with moyamoya disease  
 
Conclusions 
This study profiled neurocognitive function in adult patients with moyamoya disease 
using structured neuropsychological tasks. We showed that a broad range of cognitive 
functions is disrupted particularly in the patients with difficulty in social independence. 
We found that scores from the Working Memory (WAIS-III) and Eyes tasks are a novel 
clinical approach to detect such disadvantaged subjects even if they lack obvious 
abnormalities in brain images. Our findings also reveal subtle impairments in 
intelligence function (Working Memory, WAIS-III) in the socially independent patient 
population. To obtain sufficiently powered evidence regarding the cognitive deficits 
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Table 1. Summary of clinical characteristics of each patient group   









1 1 51 F 1 bil. STA-MCA+EMS no yes 
2 1 42 F 1 lt STA-MCA+EMS no yes 
3 1 51 M 0 lt STA-MCA+EMS no yes 
4 1 44 F 9 bil. STA-MCA+EMS no no 
5 1 28 F 3 lt STA-MCA+EMS no yes 
6 2 20 F 19 bil. STA-MCA+EMS yes no 
7 2 19 M 12 bil. STA-MCA+EMS yes no 
8 2 19 F 11 bil. STA-MCA+EMS yes no 
9 2 25 M 0 no no no 
10 2 43 F 35 bil. STA-MCA+EMS no no 
Group 1: patients without difficulty in social independence; Group 2: patients with difficulty in social independence;  
y.o.; years old; y, years; bil., bilateral; STA-MCA, superficial temporal artery-middle cerebral artery bypass; EMS, 




Table 2. Summary of radiological features of each patient group     
Case No. Group Lesions on MR imaging   SPECT findings  
  minor stroke bleeding  rest CVR 
1 1 - -  preserved  impaired in bil. ACA and MCA territory 
2 1 - lt. paraventricular region  preserved preserved 
3 1 lt. basal ganglia -  impaired in lt. MCA territory impaired in lt. MCA territory 
4 1 - -  preserved impaired in bil. ACA and MCA territory 
5 1 - -  preserved impaired in bil. ACA territory 
6 2 rt. frontal lobe CoI. -  impaired in rt. ACA territory impaired in rt. ACA territory 
7 2 - -  preserved impaired in bil. ACA and MCA territory 
8 2 bil. occipital and temporal lobe CoI. -  impaired in bil. PCA territory impaired in bil. ACA, MCA and PCA territory 
9 2 - -  impaired in rt. ACA and MCA territory impaired in rt. ACA and MCA territory 
10 2 - -  preserved impaired in bil. ACA and MCA territory 
Group 1:  patients without difficulty in social independence; Group 2: patients with difficulty in social independence; CVR: cerebrovascular reserve 


















Table 3. Summary of clinical variables and neuropsychological assessments in each group 
 Group1 (n=5)  Group2 (n=5)  Statistics 
 Mean (S.D.)  Mean (S.D.)  p 
Clinical variables      
 Age (y.o.) 43.2 (9.4)  25.2 (10.3)  0.0273* 
disease duration (y.) 2.8 (3.6)  15.4 (12.9)  0.09 
Intelligence (WAIS-III)      
Verbal IQ 103.6 (17.5)  67.2 (6)  0.009** 
Performance IQ 95.6 (10.7)  60.6 (10.5)  0.0086** 
Full Scale IQ 100 (15.2)  61.4 (6.9)  0.009** 
Verbal Comprehension 108.2 (19)  72.4 (15.4)  0.0088** 
Perceptual Organization 98.6 (12.5)  63.6 (7.6)  0.009** 
Working memory 91.8 (11.2)  61.4 (3.3)  0.008** 
Processing Speed  98 (8.6)  62.4 (12.8)  0.009** 
Memory (WMS-R)      
Verbal Index 99.2 (26.9)  69.6 (7.2)  0.1161 
Visual Index 111.6 (12)  76.8 (28.9)  0.0749 
General Index 103.2 (25.4)  65 (14.3)  0.0283* 
Attn./Conc.Index 100.6 (8.9)  68.4 (14)  0.009** 
Delayed Index 106 (24.3)  64.4 (16)  0.0283* 
Frontal lobe functions      
Frontal assessment battery 16.8 (0.8)  16.6 (1.1)  0.8266 
Trail Making Test A 35 (17.4)  72.8 (30.4)  0.0593 
Trail Making Test B 71.8 (24.4)  120.4 (37.4)  0.0465* 
Wisconsin Card Sorting Test 3.8 (2.3)  3 (2)  0.5232 
Go/NoGO task 276.2 (39)  330.8 (122.5)  0.6015 
NoGo/Go task 99.2 (9.2)  105.2 (27)  0.754 
Apathy Scale 13.8 (2.5)  16.6 (3.6)  0.2418 
Theory of Mind (Eyes)  24 (3.2)  16.8 (1.6)  0.0086** 
Group 1, patients without difficulty in social independence; Group 2, patients with difficulty 
with difficulty in social independence; S.D., standard deviation; y.o., years old; WAIS-III, 
Wechsler Adult Intelligence Scale-Third Edition; WMS-R, Wechsler Memory Scale-Revised; 


















Table 4. Discriminate analysis for prediction model 
Neuropsychological test F value P value (Prob>F) 
Intelligence (WAIS-III)   
Verbal IQ 0.807 0.404 
Performance IQ 0.282 0.614 
Full Scale IQ 0.69 0.438 
Verbal Comprehension 0.087 0.778 
Perceptual Organization 0.118 0.743 
Working memory 16.75    0.005** 
Processing Speed  0.033 0.861 
Memory (WMS-R)   
Verbal Index 0.014 0.911 
Visual Index 0.017 0.901 
General Index 0.002 0.964 
Attn./Conc.Index 0.139 0.723 
Delayed Index 0.143 0.719 
Frontal lobe function   
Frontal assessment battery 0.063 0.811 
Trail Making Test A 0.792 0.408 
Trail Making Test B 1.662 0.245 
Wisconsin Card Sorting Test 0.19 0.678 
Go/No GO task 0.059 0.817 
NoGo/Go task 0.231 0.648 
Apathy Scale 1.073 0.340 
Theory of Mind (Eyes)  8.636  0.022* 
WAIS-III, Wechsler Adult Intelligence Scale-Third Edition; WMS-R, 
Wechsler Memory Scale-Revised; *P < 0.05, **P < 0.01 
 
